skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Nome da Publicação: Cancer Chemotherapy And Pharmacology remover assunto: Medicine remover assunto: Original Article remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects

Zanellato, Ilaria ; Boidi, Carla Doriana ; Lingua, Guido ; Betta, Pier-Giacomo ; Orecchia, Sara ; Monti, Elena ; Osella, Domenico

Cancer chemotherapy and pharmacology, 2011-02, Vol.67 (2), p.265-273 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
2
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

Molina, Ana M. ; Hutson, Thomas E. ; Larkin, James ; Gold, Anne M. ; Wood, Karen ; Carter, Dave ; Motzer, Robert ; Michaelson, M. Dror

Cancer chemotherapy and pharmacology, 2014-01, Vol.73 (1), p.181-189 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
3
The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma
The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma

de Almeida, Luciana Y. ; Mariano, Flávia S. ; Bastos, Débora C. ; Cavassani, Karen A. ; Raphelson, Janna ; Mariano, Vânia S. ; Agostini, Michelle ; Moreira, Fernanda S. ; Coletta, Ricardo D. ; Mattos-Graner, Renata O. ; Graner, Edgard

Cancer chemotherapy and pharmacology, 2020-02, Vol.85 (2), p.321-330 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer

Bun, Seiko ; Yunokawa, Mayu ; Ebata, Takahiro ; Shimomura, Akihiko ; Shimoi, Tatsunori ; Kodaira, Makoto ; Yonemori, Kan ; Shimizu, Chikako ; Fujiwara, Yasuhiro ; Kato, Tomoyasu ; Makino, Yoshinori ; Hayashi, Yoshikazu ; Tamura, Kenji

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.745-752 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
5
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

Köstek, Osman ; Yılmaz, Erdem ; Hacıoğlu, Muhammet Bekir ; Demircan, Nazım Can ; Gökyer, Ali ; Uzunoğlu, Sernaz ; Tunçbilek, Nermin ; Çiçin, İrfan ; Erdoğan, Bülent

Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.735-742 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features
Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features

Kim, Jwa Hoon ; Park, Inkeun ; Lee, Jae Lyun

Cancer chemotherapy and pharmacology, 2016-08, Vol.78 (2), p.325-332 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells
In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells

Mousavi, Elham ; Tavakolfar, Shahrzad ; Almasirad, Ali ; Kooshafar, Zahra ; Dehghani, Soudeh ; Afsharinasab, Ahoo ; Amanzadeh, Amir ; Shafiee, Samira ; Salimi, Mona

Cancer chemotherapy and pharmacology, 2017-06, Vol.79 (6), p.1195-1203 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
8
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study

Merchan, Jaime R. ; Qin, Rui ; Pitot, Henry ; Picus, Joel ; Liu, Glenn ; Fitch, Tom ; Maples, William J. ; Flynn, Patrick J. ; Fruth, Briant F. ; Erlichman, Charles

Cancer chemotherapy and pharmacology, 2015-03, Vol.75 (3), p.485-493 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer

Song, Taejong ; Kim, Min Kyu ; Lee, Yoo-Young ; Choi, Chel Hun ; Kim, Tae-Joong ; Lee, Jeong-Won ; Kim, Byoung-Gie ; Bae, Duk Soo

Cancer chemotherapy and pharmacology, 2013-09, Vol.72 (3), p.653-660 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
10
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

Koinis, Filippos ; Polyzos, Aristidis ; Christopoulou, Athina ; Zafeiriou, Zafeiris ; Emmanouilidis, Christos ; Papadimitraki, Elisavet ; Kalykaki, Antonia ; Kalbakis, Kostas ; Samonis, George ; Georgoulias, Vassilis

Cancer chemotherapy and pharmacology, 2014-04, Vol.73 (4), p.819-825 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2011  (3)
  2. 2011Até2013  (2)
  3. 2014Até2015  (3)
  4. 2016Até2019  (4)
  5. Após 2019  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.